International Patent: MIXTURE OF CD19 CAR T CELLS AND CD22 CAR T CELLS FOR THE TREATMENT OF HIGH-RISK/RELAPSED HAEMATOLOGICAL MALIGNANCIES

GENEVA, Aug. 14 -- UCL BUSINESS LTD filed a patent application (GB2026/050156) for “MIXTURE OF CD19 CAR T CELLS AND CD22 CAR T CELLS FOR THE TREATMENT OF HIGH-RISK/RELAPSED HAEMATOLOGICAL MALIGNANCIES”. With publication no. WO/2026/167361, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 40/11

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....